Given the association of hepatic gene expression of BCAT1 and NAFLD outcomes, we investigated whether DNA methylation is specifically associated with altered gene expression of BCAT1 and advanced fibrosis and/or NAFLD related morbidity and mortality as a way of validating our gene expression results. This evidence concerns the gene BCAT1 and metabolic dysfunction-associated steatotic liver disease.